Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment
Noriaki Nagai,1 Fumihiko Ogata,1 Hiroko Otake,1 Yosuke Nakazawa,2 Naohito Kawasaki1 1Faculty of Pharmacy, Kindai University, Higashi-Osaka, Osaka, Japan; 2Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan Purpose: In the clinical setting, raloxifene, a second-generation selective estro...
Main Authors: | Nagai N, Ogata F, Otake H, Nakazawa Y, Kawasaki N |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-09-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/design-of-a-transdermal-formulation-containing-raloxifene-nanoparticle-peer-reviewed-article-IJN |
Similar Items
-
Formulation Development for Transdermal Delivery of Raloxifene, a Chemoprophylactic Agent against Breast Cancer
by: Deepal Vora, et al.
Published: (2022-03-01) -
Design of a Transdermal Sustained Release Formulation Based on Water-Soluble Ointment Incorporating Tulobuterol Nanoparticles
by: Noriaki Nagai, et al.
Published: (2022-11-01) -
A Snapshot of Transdermal and Topical Drug Delivery Research in Canada
by: Mahdi Roohnikan, et al.
Published: (2019-06-01) -
Ionically Crosslinked Complex Gels Loaded with Oleic Acid-Containing Vesicles for Transdermal Drug Delivery
by: Wing-Fu Lai, et al.
Published: (2020-08-01) -
O/W microemulsion droplets diffuse through hydrogel network to achieve enhanced transdermal drug delivery
by: Lina Shen, et al.
Published: (2021-01-01)